ReviewMolecular biotechnology2026
Industrial Bioreactor Technologies for Modern Biomanufacturing: Recent Applications in Microbial, Mammalian, and Plant-Based Systems.
Review in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioreactors are known for their ability to provide a controlled environment for the cultivation of various biological systems. While microbial systems are primarily known for their speed and cost advantages in industrial enzyme and simple protein production, mammalian cell systems continue to be the platform for clinical therapies due to their complex glycosylation requirements and viral vector production. Moreover, plant cell-based systems offer a new production paradigm focused on biosafety and sustainability. The main challenge with traditional bioreactors is the shear stress that occurs when trying to deliver equal oxygen and nutrients to every cell in large-scale production, damaging the delicate cells. Another challenge is the uncontrolled microenvironments that lead to deviations in product quality. As in other fields, with the changing application and engineering approaches, the diversification and development of bioreactor systems continues unabated. Looking to the future, it is predicted that the transformation in bioreactor technologies, driven by digitalization, artificial intelligence, and customized bioreactor mechanisms, will close the gaps in traditional approaches. This review aims to provide a comprehensive and up-to-date overview of bioreactor technologies with a particular focus on their biological diversity, engineering design, and functional principles by systematically examining microbial, mammalian, and plant bioreactor systems.
Indexed as
Identifiers
42449072What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.